L01FF09 - tislelizumab : Belongs to the class of PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.
A02BC04 - rabeprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
A02BC04 - rabeprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
M02AA15 - diclofenac : Belongs to the class of non-steroidal antiinflammatory preparations for topical use. Used in the treatment of joint and muscular pains.
J05AR22 - emtricitabine, tenofovir alafenamide, darunavir and cobicistat : Belongs to the class of antivirals for treatment of HIV infections, combinations.
C05AA08 - fluocortolone : Belongs to the class of products containing corticosteroids for topical use. Used in the treatment of hemorrhoids and anal fissures.
C05AA08 - fluocortolone : Belongs to the class of products containing corticosteroids for topical use. Used in the treatment of hemorrhoids and anal fissures.
D07CC01 - betamethasone and antibiotics : Belongs to the class of potent (group III) corticosteroids, in combination with antibiotics. Used in the treatment of dermatological diseases.
D07CA01 - hydrocortisone and antibiotics : Belongs to the class of weak (group I) corticosteroids, in combination with antibiotics. Used in the treatment of dermatological diseases.
D01AC20 - imidazoles/triazoles in combination with corticosteroids : Belongs to the class of imidazole and triazole derivatives. Used in the topical treatment of fungal infection.
R03AK11 - formoterol and fluticasone : Belongs to the class of adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics. Used in the treatment of obstructive airway diseases.
R03AK11 - formoterol and fluticasone : Belongs to the class of adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics. Used in the treatment of obstructive airway diseases.
R03AK11 - formoterol and fluticasone : Belongs to the class of adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics. Used in the treatment of obstructive airway diseases.
V03AC03 - deferasirox : Belongs to the class of iron chelating agents. Used in the management of chronic iron overload associated with blood transfusion.
V03AC03 - deferasirox : Belongs to the class of iron chelating agents. Used in the management of chronic iron overload associated with blood transfusion.
A10AD01 - insulin (human) : Belongs to the class of intermediate-acting combined with fast-acting insulins and analogues. Used in the treatment of diabetes.
A10AD01 - insulin (human) : Belongs to the class of intermediate-acting combined with fast-acting insulins and analogues. Used in the treatment of diabetes.
A10AD05 - insulin aspart : Belongs to the class of intermediate-acting combined with fast-acting insulins and analogues. Used in the treatment of diabetes.
A10AD06 - insulin degludec and insulin aspart : Belongs to the class of intermediate-acting combined with fast-acting insulins and analogues. Used in the treatment of diabetes.
A10AE56 - insulin degludec and liraglutide : Belongs to the class of long-acting insulins and analogues for injection. Used in the treatment of diabetes.
L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor / Receptors) inhibitors. Used in the treatment of cancer.
L01FY01 - pertuzumab and trastuzumab : Belongs to the class of combinations of monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.
L01FY01 - pertuzumab and trastuzumab : Belongs to the class of combinations of monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.
L01FF05 - atezolizumab : Belongs to the class of PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.
L01FF05 - atezolizumab : Belongs to the class of PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.
J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.
J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.
D07BC01 - betamethasone and antiseptics : Belongs to the class of potent (group III) corticosteroids, in combination with antiseptics. Used in the treatment of dermatological diseases.